Advertisement

You are subscribed to the Dermatology Times eNews.

MAUI DERM
Twitter Facebook

View Online  |  Download Magazine  |  Share With A Colleague  |  Print & Digital Subscribe  |  eNewsletter Subscribe

WELCOME TO MAUI DERM 2015

January 28, 2015

Thank you for reading the Dermatology Times Maui Derm 2015 conference e-newsletter.

Click to see all our coverage.

MONDAY AND TUESDAY HIGHLIGHTS

Highlights in dermatology news from 2014

Highlights of dermatology news in 2014 include promising data about nivolumab (Opdivo, Bristol-Myers Squibb) for melanoma and a new class of drugs that may help patients with stubborn cases of alopecia areata, a top dermatologist told attendees at the Maui Derm 2015 meeting Monday. Research to know about

Severe psoriasis may indicate systemic inflammation

Psoriasis isn't always just a skin disease, dermatologists learned at the Maui Derm 2015 conference this week. Physicians are becoming increasingly aware that severe cases of psoriasis are indications of dangerous systemic inflammation. Newer drugs make a difference

RELATED ARTICLES

» FDA approves secukinumab for adults with psoriasis

» Final trial phase begins for drug's plaque-psoriasis indication

» FDA accelerates approval of melanoma drug

Advertisement

Maui Derm @Maui_Derm

What's new regarding infectious disease? Dr Tyring provides us with clinical pearls... http://mauiderm.com/?p=6838


Maui Derm @Maui_Derm

Are you using dermoscopy in clinical practice? Here are some key points from Dr Marghoob... http://mauiderm.com/?p=6836

Bio-Oil USA ‏@BioOilUS

Keep up to date with clinical pearls from @Maui_Derm 2015 all this week at http://mauiderm.com/news/ #dermatology

Maui Derm @Maui_Derm

Are you treating facial AKs? Drs Martin and Rosen provide pearls that may help you in clinical practice... http://mauiderm.com/?p=6834

David Laub, MD @LaubDermatology

We are excited to participate in the 2015 Maui Derm Conference http://mauiderm.com/ 

Top Tweets

We welcome your feedback!
Please send your comments to:

Heather Onorati

Content Channel Director

Dermatology Times

honorati@advanstar.com

DISCLAIMER:
This information has been independently developed and provided by the editors of Dermatology Times.
The sponsors do not endorse and are not responsible for the accuracy of the content or for practices or standards of non-sponsor sources. These articles may discuss regimens that have not been approved by the FDA.
For full prescribing information including indications, contraindications, warnings, precautions, and adverse experiences, please see the appropriate manufacturer's product circular.

Editorial Questions? Contact the Editorial Team Click Here. Sales, Reprints, Classified questions? Contact the Sales Team Click Here.

ModernMedicine logoUBM Advanstar logo